Fremgangsmåde til at forudsige den kliniske reaktion på onkolytisk parvovirus H1 (H-1PV)-behandling af en patient, der mistænkes for at lide af cancer, ved at måle ekspressionsniveauerne af lamininer og/eller galectiner som biomarkører i en patients prøve

The present invention concerns the use of laminins and/or galectins as biomarker(s) for predicting the outcome of the treatment with oncolytic parvovirus H1 (H-1PV) in a cancer patient.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Kulkarni, Amit, FERREIRA, Tiago, Marchini, Antonio, Grewenig, Annabel, ROMMELAERE, Jean, Marttila, Tiina
Format:	Patent
Sprache:	dan
Schlagworte:	HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention concerns the use of laminins and/or galectins as biomarker(s) for predicting the outcome of the treatment with oncolytic parvovirus H1 (H-1PV) in a cancer patient.